Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Patient Classifier for Ependymal Tumours Based on Molecular Subgroups Using Patient Similarity Networks
EF 2021-22
Résumé
Ependymomas are tumours of the central nervous system that occur in both children and adults, and exabit a large degree of diversity in clinical progression and treatment outcomes. As such, the ability to identify tumour subtypes that are associated with the underlying biological mechanisms is important, as it informs clinical decisions such as treatment planning. While the grading of ependymal tumours is traditionally based on histopathological diagnosis (from the examination of tumour tissues under a microscope), recent approaches based on molecular characteristics have proven to be more consistent, and better associated with clinical progression. As such, the creation of computational systems based on this type of data, which allow classification of new patients into different risk groups, would further our understanding of ependymomas and improve treatment outcomes for patients. This project aims to create a classifier based on the molecular subtypes of ependymal tumours, and evaluate its performance. Analysis of the classifier model will allow insights regarding the biological features that are most associated with different subtypes, and the identification of mechanisms of disease and potential treatment targets. This will be done through the creation of Patient Similarity Networks, which are a computational tool used to integrate different types of data into a single graphical representation, in which patients are clustered and classified based on their similarities. The resulting tool will allow a more personalized approach to the treatment of ependymal tumours, and further our understanding of the mechanisms underlying disease progression.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466975
Name
Saderi Moujan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Patient Classifier for Ependymal Tumours Based on Molecular Subgroups Using Patient Similarity Networks
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Ependymoma; Molecular Classification; Multi-Omics; Patient Classifier; Precision Medicine
Abstract
Ependymomas are tumours of the central nervous system that occur in both children and adults, and exabit a large degree of diversity in clinical progression and treatment outcomes. As such, the ability to identify tumour subtypes that are associated with the underlying biological mechanisms is important, as it informs clinical decisions such as treatment planning. While the grading of ependymal tumours is traditionally based on histopathological diagnosis (from the examination of tumour tissues under a microscope), recent approaches based on molecular characteristics have proven to be more consistent, and better associated with clinical progression. As such, the creation of computational systems based on this type of data, which allow classification of new patients into different risk groups, would further our understanding of ependymomas and improve treatment outcomes for patients. This project aims to create a classifier based on the molecular subtypes of ependymal tumours, and evaluate its performance. Analysis of the classifier model will allow insights regarding the biological features that are most associated with different subtypes, and the identification of mechanisms of disease and potential treatment targets. This will be done through the creation of Patient Similarity Networks, which are a computational tool used to integrate different types of data into a single graphical representation, in which patients are clustered and classified based on their similarities. The resulting tool will allow a more personalized approach to the treatment of ependymal tumours, and further our understanding of the mechanisms underlying disease progression.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Saderi, Moujan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~